Funds · 13F holdings

Alphabet Inc.

13F holdings for Q2 2026 · Mountain View, CA · filed August 7, 2026

Alphabet Inc. reported $99.1B in 13F securities across 28 holdings for Q2 2026, in a Form 13F filed August 7, 2026. The largest positions were SPCX (95.0%), PL (1.2%), ASTS (0.8%). Reported value rose 2367.4% from the quarter before. It opened 3 new positions, added to 0, trimmed 4 and sold out of 1.

13F value Q2 2026
$99.1B
Holdings
28
Change vs prior quarter
+2367.4%
Rank by 13F value
#113

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Top holdings

StockValueWeightSharesChange in sharesMove
SPCX Space Exploration Technologies Corp.$94.2B95.0%551,189,500NewNew
PL Planet Labs PBC$1.2B1.2%35,248,8930%Unchanged
ASTS AST SpaceMobile Inc.$795M0.8%8,943,4860%Unchanged
CME CME Group Inc.$769M0.8%3,484,0200%Unchanged
ARM Arm Holdings plc$695M0.7%1,960,7840%Unchanged
RVMD Revolution Medicines Inc.$552M0.6%2,946,619-10.5%Trimmed
FRSH Freshworks Inc.$164M0.2%16,206,6430%Unchanged
PBLS Parabilis Medicines Inc.$135M0.1%4,919,498NewNew
TEM Tempus AI Inc.$89.9M0.1%1,551,1020%Unchanged
GTLB GitLab Inc.$83.2M0.1%2,724,7120%Unchanged
PATH UiPath Inc.$76.5M0.1%7,034,3370%Unchanged
LIFE Ethos Technologies Inc.$65.7M0.1%3,622,604-3.9%Trimmed
PRME Prime Medicine Inc.$61.1M0.1%16,562,4980%Unchanged
FRVO Fervo Energy Company$51.5M0.1%1,760,732NewNew
PAYP PayPay Corporation$44.8M0.0%3,125,0000%Unchanged
MAZE Maze Therapeutics Inc.$41.4M0.0%1,388,5830%Unchanged
RLAY Relay Therapeutics Inc.$26.4M0.0%1,410,029-9.9%Trimmed
BBOT BridgeBio Oncology Therapeutics Inc.$21.5M0.0%2,823,1260%Unchanged
OSCR Oscar Health Inc.$13.7M0.0%481,9880%Unchanged
BEAM Beam Therapeutics Inc.$11.0M0.0%321,6040%Unchanged
VERA Vera Therapeutics Inc.$10.4M0.0%241,2640%Unchanged
SANA Sana Biotechnology Inc.$9.8M0.0%2,812,5000%Unchanged
GLUE Monte Rosa Therapeutics Inc.$9.0M0.0%372,474-45.6%Trimmed
LYEL Lyell Immunopharma Inc.$4.1M0.0%293,2560%Unchanged
FIG Figma Inc.$3.9M0.0%215,5820%Unchanged

Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $99.1B in share positions; options and bonds count in the 13F value but not here.

The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 3 new, 0 added, 4 trimmed, 1 sold out.

Sector mix

13F value by quarter

Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
Reported 13F value: Q1 2024 $2.5B, Q2 2024 $2.0B, Q3 2024 $1.8B, Q4 2024 $1.7B, Q1 2025 $1.6B, Q2 2025 $2.1B, Q3 2025 $2.4B, Q4 2025 $2.6B, Q1 2026 $4.0B, Q2 2026 $99.1B.

More holdings

StockValueWeightSharesChange in sharesMove
SPRO Spero Therapeutics Inc.$2.0M0.0%889,9790%Unchanged
HYPR Hyperfine Inc.$1.2M0.0%898,7200%Unchanged
AUTL Autolus Therapeutics plc$1.1M0.0%698,2620%Unchanged

Questions about Alphabet Inc.

What does Alphabet Inc. own?
In its Form 13F for Q2 2026, Alphabet Inc. reported 28 holdings worth $99.1B. The five largest were SPCX, PL, ASTS, CME, ARM.
What did Alphabet Inc. buy and sell in Q2 2026?
Alphabet Inc. opened 3 new positions, added to 0, trimmed 4 and sold out of 1 compared with the quarter before.
When did Alphabet Inc. file its latest 13F?
Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed August 7, 2026.

From Form 13F filed by Alphabet Inc. (SEC CIK 0001652044) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds